Literature DB >> 23547110

Pathway-based personalized analysis of cancer.

Yotam Drier1, Michal Sheffer, Eytan Domany.   

Abstract

We introduce Pathifier, an algorithm that infers pathway deregulation scores for each tumor sample on the basis of expression data. This score is determined, in a context-specific manner, for every particular dataset and type of cancer that is being investigated. The algorithm transforms gene-level information into pathway-level information, generating a compact and biologically relevant representation of each sample. We demonstrate the algorithm's performance on three colorectal cancer datasets and two glioblastoma multiforme datasets and show that our multipathway-based representation is reproducible, preserves much of the original information, and allows inference of complex biologically significant information. We discovered several pathways that were significantly associated with survival of glioblastoma patients and two whose scores are predictive of survival in colorectal cancer: CXCR3-mediated signaling and oxidative phosphorylation. We also identified a subclass of proneural and neural glioblastoma with significantly better survival, and an EGF receptor-deregulated subclass of colon cancers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23547110      PMCID: PMC3631698          DOI: 10.1073/pnas.1219651110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Outcome signature genes in breast cancer: is there a unique set?

Authors:  Liat Ein-Dor; Itai Kela; Gad Getz; David Givol; Eytan Domany
Journal:  Bioinformatics       Date:  2004-08-12       Impact factor: 6.937

3.  A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression.

Authors:  Warren P Mason; Karl Belanger; Garth Nicholas; Isabelle Vallières; David Mathieu; Petr Kavan; Annick Desjardins; Antonio Omuro; Didier Reymond
Journal:  J Neurooncol       Date:  2011-11-03       Impact factor: 4.130

Review 4.  Tyrosine kinases as targets for cancer therapy.

Authors:  Daniela S Krause; Richard A Van Etten
Journal:  N Engl J Med       Date:  2005-07-14       Impact factor: 91.245

Review 5.  Ras, PI(3)K and mTOR signalling controls tumour cell growth.

Authors:  Reuben J Shaw; Lewis C Cantley
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

6.  Approaches to complex pathways in molecular epidemiology: summary of a special conference of the American Association for Cancer Research.

Authors:  Duncan C Thomas; James W Baurley; Elizabeth E Brown; Jane C Figueiredo; Alisa Goldstein; Aditi Hazra; Robin T Wilson; Nathaniel Rothman
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

7.  Molecular classification of prostate cancer using curated expression signatures.

Authors:  Elke K Markert; Hideaki Mizuno; Alexei Vazquez; Arnold J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

8.  Pathway analysis of expression data: deciphering functional building blocks of complex diseases.

Authors:  Frank Emmert-Streib; Galina V Glazko
Journal:  PLoS Comput Biol       Date:  2011-05-26       Impact factor: 4.475

9.  Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.

Authors:  Jeffrey C Lee; Igor Vivanco; Rameen Beroukhim; Julie H Y Huang; Whei L Feng; Ralph M DeBiasi; Koji Yoshimoto; Jennifer C King; Phioanh Nghiemphu; Yuki Yuza; Qing Xu; Heidi Greulich; Roman K Thomas; J Guillermo Paez; Timothy C Peck; David J Linhart; Karen A Glatt; Gad Getz; Robert Onofrio; Liuda Ziaugra; Ross L Levine; Stacey Gabriel; Tomohiro Kawaguchi; Keith O'Neill; Haumith Khan; Linda M Liau; Stanley F Nelson; P Nagesh Rao; Paul Mischel; Russell O Pieper; Tim Cloughesy; Daniel J Leahy; William R Sellers; Charles L Sawyers; Matthew Meyerson; Ingo K Mellinghoff
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

10.  PID: the Pathway Interaction Database.

Authors:  Carl F Schaefer; Kira Anthony; Shiva Krupa; Jeffrey Buchoff; Matthew Day; Timo Hannay; Kenneth H Buetow
Journal:  Nucleic Acids Res       Date:  2008-10-02       Impact factor: 16.971

View more
  115 in total

Review 1.  Principles and methods of integrative genomic analyses in cancer.

Authors:  Vessela N Kristensen; Ole Christian Lingjærde; Hege G Russnes; Hans Kristian M Vollan; Arnoldo Frigessi; Anne-Lise Børresen-Dale
Journal:  Nat Rev Cancer       Date:  2014-05       Impact factor: 60.716

2.  Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients.

Authors:  Claudia Omarini; Stefania Bettelli; Cecilia Caprera; Samantha Manfredini; Federica Caggia; Giorgia Guaitoli; Luca Moscetti; Angela Toss; Laura Cortesi; Shaniko Kaleci; Antonino Maiorana; Stefano Cascinu; Pier Franco Conte; Federico Piacentini
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

3. 

Authors:  Botao Fa; Chengwen Luo; Zhou Tang; Yuting Yan; Yue Zhang; Zhangsheng Yu
Journal:  EBioMedicine       Date:  2019-05-14       Impact factor: 8.143

4.  FREQUENT SUBGRAPH MINING OF PERSONALIZED SIGNALING PATHWAY NETWORKS GROUPS PATIENTS WITH FREQUENTLY DYSREGULATED DISEASE PATHWAYS AND PREDICTS PROGNOSIS.

Authors:  Arda Durmaz; Tim A D Henderson; Douglas Brubaker; Gurkan Bebek
Journal:  Pac Symp Biocomput       Date:  2017

5.  Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome.

Authors:  Sungyong You; Beatrice S Knudsen; Nicholas Erho; Mohammed Alshalalfa; Mandeep Takhar; Hussam Al-Deen Ashab; Elai Davicioni; R Jeffrey Karnes; Eric A Klein; Robert B Den; Ashley E Ross; Edward M Schaeffer; Isla P Garraway; Jayoung Kim; Michael R Freeman
Journal:  Cancer Res       Date:  2016-06-14       Impact factor: 12.701

6.  Pathway-based personalized analysis of breast cancer expression data.

Authors:  Anna Livshits; Anna Git; Garold Fuks; Carlos Caldas; Eytan Domany
Journal:  Mol Oncol       Date:  2015-04-29       Impact factor: 6.603

7.  Pathway and network analysis of cancer genomes.

Authors:  Pau Creixell; Jüri Reimand; Syed Haider; Guanming Wu; Tatsuhiro Shibata; Miguel Vazquez; Ville Mustonen; Abel Gonzalez-Perez; John Pearson; Chris Sander; Benjamin J Raphael; Debora S Marks; B F Francis Ouellette; Alfonso Valencia; Gary D Bader; Paul C Boutros; Joshua M Stuart; Rune Linding; Nuria Lopez-Bigas; Lincoln D Stein
Journal:  Nat Methods       Date:  2015-07       Impact factor: 28.547

8.  Personalized characterization of diseases using sample-specific networks.

Authors:  Xiaoping Liu; Yuetong Wang; Hongbin Ji; Kazuyuki Aihara; Luonan Chen
Journal:  Nucleic Acids Res       Date:  2016-09-04       Impact factor: 16.971

9.  Emergence of pathway-level composite biomarkers from converging gene set signals of heterogeneous transcriptomic responses.

Authors:  Samir Rachid Zaim; Qike Li; A Grant Schissler; Yves A Lussier
Journal:  Pac Symp Biocomput       Date:  2018

10.  Covariance-based analyses of biological pathways.

Authors:  P Danaher; D Paul; P Wang
Journal:  Biometrika       Date:  2015-09-01       Impact factor: 2.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.